Literature DB >> 14563578

Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial.

John G Webb1, April M Lowe, Timothy A Sanborn, Harvey D White, Lynn A Sleeper, Ronald G Carere, Christopher E Buller, S Chiu Wong, Jean Boland, Vlad Dzavik, Mark Porway, Gordon Pate, Geoffrey Bergman, Judith S Hochman.   

Abstract

OBJECTIVES: We examined the clinical, angiographic, and procedural characteristics determining survival after percutaneous coronary intervention (PCI) for cardiogenic shock.
BACKGROUND: The SHOCK (SHould we emergently revascularize Occluded coronaries for Cardiogenic shocK?) trial prospectively enrolled patients with shock complicating acute myocardial infarction (MI). Patients were randomized to a strategy of early revascularization or initial medical stabilization.
METHODS: Patients randomized to early revascularization underwent PCI or bypass surgery on the basis of predefined clinical criteria. Patients randomized to early revascularization who underwent PCI and had angiographic films available for analysis are the subject of this report (n = 82).
RESULTS: The median time from MI to PCI was 11 h. The majority of patients had occluded culprit arteries (Thrombolysis In Myocardial Infarction [TIMI] grade 0 or 1 flow in 62%) and multivessel disease (81%). One-year mortality in PCI patients was 50%. Mortality was 39% if PCI was successful but 85% if unsuccessful (p < 0.001). Mortality was 38% if TIMI flow grade 3 was achieved, 55% with TIMI grade 2 flow, and 100% with TIMI grade 0 or 1 flow (p < 0.001). Mortality was 67% if severe mitral regurgitation was documented. Independent correlates of mortality were as follows: increasing age (p < 0.001), lower systolic blood pressure (p = 0.009), increasing time from randomization to PCI (p = 0.019), lower post-PCI TIMI flow (0/1 vs. 2/3) (p < 0.001), and multivessel PCI (p = 0.040).
CONCLUSIONS: Restoration of coronary blood flow is a major predictor of survival in cardiogenic shock. Benefit appears to extend beyond the generally accepted 12-h post-infarction window. Surgery should be considered in shock patients with severe mitral insufficiency or multivessel disease not amenable to relatively complete percutaneous revascularization.

Entities:  

Mesh:

Year:  2003        PMID: 14563578     DOI: 10.1016/s0735-1097(03)01050-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  39 in total

1.  Predictors of outcome after percutaneous treatment for cardiogenic shock.

Authors:  A G C Sutton; P Finn; J A Hall; A A Harcombe; R A Wright; M A de Belder
Journal:  Heart       Date:  2005-03       Impact factor: 5.994

Review 2.  Phagocytosis of apoptotic cells: a matter of balance.

Authors:  C J G de Almeida; R Linden
Journal:  Cell Mol Life Sci       Date:  2005-07       Impact factor: 9.261

3.  Percutaneous coronary intervention: recommendations for good practice and training.

Authors:  K D Dawkins; T Gershlick; M de Belder; A Chauhan; G Venn; P Schofield; D Smith; J Watkins; H H Gray
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

Review 4.  Familial hypobetalipoproteinemia: genetics and metabolism.

Authors:  G Schonfeld; X Lin; P Yue
Journal:  Cell Mol Life Sci       Date:  2005-06       Impact factor: 9.261

5.  Clinical characteristics and prognostic factors in acute coronary syndrome patients complicated with cardiogenic shock in Japan: analysis from the Japanese Circulation Society Cardiovascular Shock Registry.

Authors:  Kazuo Sakamoto; Tetsuya Matoba; Masahiro Mohri; Yasushi Ueki; Yasuyuki Tsujita; Masao Yamasaki; Nobuhiro Tanaka; Yohei Hokama; Motoki Fukutomi; Katsutaka Hashiba; Rei Fukuhara; Satoru Suwa; Hirohide Matsuura; Eizo Tachibana; Naohiro Yonemoto; Ken Nagao
Journal:  Heart Vessels       Date:  2019-02-04       Impact factor: 2.037

Review 6.  [Coronary artery disease : Interventional and operative therapeutic options after cardiac arrest].

Authors:  M Behnes; K Mashayekhi; M Borggrefe; I Akin
Journal:  Herz       Date:  2017-04       Impact factor: 1.443

Review 7.  Mechanical circulatory support in acute heart failure.

Authors:  Igor D Gregoric
Journal:  Tex Heart Inst J       Date:  2012

8.  Intra-aortic balloon pump counterpulsation: are we optimizing the management of cardiogenic shock?

Authors:  F Shahid; M Akhtar; F Khan; C A A Chahal
Journal:  J R Soc Med       Date:  2013-02       Impact factor: 5.344

9.  Initial culprit-only versus initial multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: results from the Ibaraki Cardiovascular Assessment Study registry.

Authors:  Daisuke Abe; Akira Sato; Tomoya Hoshi; Noriyuki Takeyasu; Masako Misaki; Mayu Hayashi; Kazutaka Aonuma
Journal:  Heart Vessels       Date:  2013-03-26       Impact factor: 2.037

Review 10.  New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs.

Authors:  A V Schally; K Szepeshazi; A Nagy; A M Comaru-Schally; G Halmos
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.